— Know what they know.
Not Investment Advice

VTRS NASDAQ

Viatris Inc.
1W: -4.6% 1M: +13.4% 3M: +3.4% YTD: +32.1% 1Y: +92.3% 3Y: +104.2% 5Y: +26.0%
$16.65
+0.19 (+1.15%)
 
Weekly Expected Move ±5.8%
$15 $16 $16 $17 $18
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Buy · Power 64 · $19.4B mcap · 1.14B float · 1.01% daily turnover · Short 51% of daily vol

Cash Flow Trends

Operating Cash Flow
$2.3B +0.6% ▲
5Y CAGR: +13.5%
Capital Expenditures
$379M -16.2% ▼
5Y CAGR: -11.1%
Free Cash Flow
$1.9B -2.0% ▼
5Y CAGR: +28.6%
Dividends Paid
$561M +2.4% ▲
Buybacks
$500M -100.2% ▼
Net Change in Cash
$612M +337.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$1.3B$2.1B$55M-$634M-$3.5B
Depreciation & Amort.$4.5B$3.0B$2.7B$2.7B$2.8B
Stock-Based Comp.$111M$116M$181M$146M$178M
Change in Working Capital-$1.8B-$923M-$711M-$319M-$2.5B
Other Non-Cash Items$797M-$1.3B$922M$1.2B$5.8B
Operating Cash Flow$3.0B$3.0B$2.8B$2.3B$2.3B
— Investing Activities —
Capital Expenditures-$509M-$489M-$377M-$326M-$379M
Acquisitions (Net)$277M$0-$668M-$350M$0
Investment Purchases-$30M-$30M-$26M-$26M-$24M
Investment Sales$30M$30M$26M$26M$24M
Other Investing$115M$2.0B$281M$2.5B-$49M
Investing Cash Flow-$118M$1.5B-$764M$1.8B-$428M
— Financing Activities —
Net Debt Issuance-$2.1B-$3.3B-$1.2B-$3.7B$0
Stock Repurchased-$17M$0-$250M-$250M-$500M
Dividends Paid-$399M-$582M-$576M-$575M-$561M
Other Financing-$496M-$20M-$230M$206M-$235M
Financing Cash Flow-$3.0B-$3.9B-$2.3B-$4.3B-$1.3B
Net Change in Cash-$144M$556M-$269M-$258M$612M
Cash End of Period$706M$1.3B$994M$736M$1.3B
Free Cash Flow$2.5B$2.5B$2.3B$2.0B$1.9B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms